Conde - Google Patents
SUPPLEMENTAL METHODS Mouse strainsConde
- Document ID
- 12299549931521846753
- Author
- Conde E
External Links
Snippet
7-week-old C57BL/6 mice were obtained from Harlan Laboratories. CD45. 1 (B6. SJL- PtprcaPep3b/BoyJ), Rag1-KO (B6. 129S7-Rag1tm1Mom/J) and STING-KO (C57BL/6J- Tmem173gt/J) mice were from the Jackson Laboratory. Batf3-KO (B6. 129S (C) …
- 230000000153 supplemental 0 title description 39
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102427563B1 (en) | Adenovirus supplemented with bispecific T cell activator | |
KR102110187B1 (en) | Nucleic acid for coding chimeric antigen feceptor protein and t lymphocyte for expression of chimeric antigen receprof prorein | |
JP7337773B2 (en) | Reagents for expanding cells expressing recombinant receptors | |
ES2717629T3 (en) | Truncated epidermal growth factor receptor (EGFRt) for selection of transduced T cells | |
TWI852977B (en) | Prostate neoantigens and their uses | |
KR20180053648A (en) | Tumor-specific anti-EGFR antibodies and their applications | |
CN110144326A (en) | A kind of antitumor T cell of targeting and its preparation method and application | |
CN115135674A (en) | Dendritic cell activating chimeric antigen receptor and uses thereof | |
CN110144328A (en) | A kind of antitumor T cell of targeting and its preparation method and application | |
AU2021236145A1 (en) | Methods for generating engineered memory-like NK cells and compositions thereof | |
KR20220141849A (en) | Neoantigens expressed in multiple myeloma and uses thereof | |
CN110526970A (en) | Target single-chain antibody, the Chimeric antigen receptor T cell and its preparation method and application of CD133 | |
CN109957018A (en) | It is a kind of to target the single-chain antibody of CD22, Chimeric antigen receptor T cell and its preparation method and application | |
JP2021534791A (en) | Improved wrench viral vector | |
JP2023527026A (en) | Enhanced Synthetic T Cell Receptors and Antigen Receptors | |
CN110526991A (en) | Target Chimeric antigen receptor, the Chimeric antigen receptor T cell and its preparation method and application of FAP | |
CN109957020A (en) | It is a kind of to target the single-chain antibody of DR5, Chimeric antigen receptor T cell and its preparation method and application | |
WO2025035746A1 (en) | Car-t cell targeting b7-h3 and co-expressing cytokine and chemokine, and use of car-t cell | |
Conde | SUPPLEMENTAL METHODS Mouse strains | |
WO2024060577A1 (en) | USE OF INTERLEUKIN 15 RECEPTOR α ARMORED CAR-T CELL IN REDUCING INTERLEUKIN 15-INDUCED CYTOTOXICITY | |
CN109957021A (en) | It is a kind of to target the single-chain antibody of CD38, Chimeric antigen receptor T cell and its preparation method and application | |
CN110526989A (en) | Target Chimeric antigen receptor, the Chimeric antigen receptor T cell and its preparation method and application of CEA | |
CN109957017A (en) | A kind of single chain antibody targeting OX40, chimeric antigen receptor T cell and preparation method and application thereof | |
RU2841311C1 (en) | Neoantigens expressed in multiple myeloma, and use thereof | |
JP2025501358A (en) | T cell receptors, methods of production and uses thereof |